Saladax Biomedical Welcomes New Guidelines from the International Association of Therapeutic Drug Monitoring and Clinical Toxicology (IATDMCT) for 5-Fluorouracil Therapy Oncology News

Saladax Biomedical Welcomes New Guidelines from the International Association of Therapeutic Drug Monitoring and Clinical Toxicology (IATDMCT) for 5-Fluorouracil Therapy

Bethlehem, PA – September 19, 2018 – Saladax Biomedical Inc., a diagnostics company providing kits…

John BuckleySeptember 19, 2018

Saladax Signs Licensing Agreement with Janssen for Antipsychotic Drug Testing Patents Psychiatry News

Saladax Signs Licensing Agreement with Janssen for Antipsychotic Drug Testing Patents

BETHLEHEM, Pa.--(BUSINESS WIRE)--Saladax Biomedical, Inc., a diagnostics company providing kits to measure drug blood levels…

John BuckleyJune 26, 2018

Saladax Receives Approval to Sell a New Line of Psychiatry Tests on the European Market Psychiatry News

Saladax Receives Approval to Sell a New Line of Psychiatry Tests on the European Market

Saladax is Advancing Personalized Medicine by Providing Doctors with Tests for Drug Levels to Better…

John BuckleyMarch 21, 2018

Saladax is Awarded “Best Poster Presentation” for Study on Individualized Dosing of Paclitaxel General NewsOncology News

Saladax is Awarded “Best Poster Presentation” for Study on Individualized Dosing of Paclitaxel

Saladax Biomedical, Inc., recently presented a study on the value of adjusting paclitaxel doses.  The…

John BuckleyOctober 14, 2017

Saladax Licenses Alzheimer’s Diagnostic Tests to Siemens Healthineers Psychiatry News

Saladax Licenses Alzheimer’s Diagnostic Tests to Siemens Healthineers

Tests can lead to early identification of Alzheimer’s Disease Bethlehem, PA--(BUSINESS WIRE)--January 18, 2017-- Saladax…

John BuckleyJanuary 18, 2017

Salvatore J. Salamone, Ph.D., Founder and CEO of Saladax Biomedical, Inc. Inducted into the New Jersey Inventors Hall of Fame General News

Salvatore J. Salamone, Ph.D., Founder and CEO of Saladax Biomedical, Inc. Inducted into the New Jersey Inventors Hall of Fame

Saladax Biomedical, Inc., the leader in developing oncology diagnostics that increase the impact of personalized…

John BuckleyOctober 28, 2016

Study Shows That Therapeutic Drug Monitoring Can Reduce Paclitaxel-Associated Neuropathy Oncology News

Study Shows That Therapeutic Drug Monitoring Can Reduce Paclitaxel-Associated Neuropathy

Saladax Biomedical, Inc., a privately held company developing and commercializing novel diagnostic tests, today announced…

John BuckleyOctober 19, 2016

Saladax Biomedical, Inc. Announces Presentation of CEPAC-TDM Study of Paclitaxel in Non-Small Cell Lung Cancer at 2015 ASCO Meeting Oncology News

Saladax Biomedical, Inc. Announces Presentation of CEPAC-TDM Study of Paclitaxel in Non-Small Cell Lung Cancer at 2015 ASCO Meeting

Large Study Confirms the Benefit to Patients of Advanced Dosing Method Saladax Biomedical, Inc. recently…

John BuckleyJune 9, 2015

Saladax Biomedical, Inc. Announces the Presentation of the CESAR Study Results for Pharmacokinetically-Guided Dosing of 5-Fluorouracil in Colorectal Cancer at 2015 ASCO Meeting Oncology News

Saladax Biomedical, Inc. Announces the Presentation of the CESAR Study Results for Pharmacokinetically-Guided Dosing of 5-Fluorouracil in Colorectal Cancer at 2015 ASCO Meeting

Advantages of a Practical Approach to Personalized Dosing of 5-FU Demonstrated Saladax Biomedical, Inc. recently…

John BuckleyJune 8, 2015

Personalized Chemotherapy Tests Cleared for Use in China Oncology News

Personalized Chemotherapy Tests Cleared for Use in China

Exposure Optimization Tests Fosun Diagnostics, a division of Fosun Pharmaceuticals, and Saladax Biomedical, Inc. today…

John BuckleyJuly 23, 2014